LATEST NEWS

  • In 2022, NeuroServo entered into a collaboration agreement with Mayo Clinic.

  • NeuroServo was the recipient of the 2021 Innovator in Residence program aimed at improving and validating health innovations.

  • NeuroServo (instant EEG for ICU and ER) announces closing of $2.2M funding round

    Click Here

  • NeuroServo announced FDA 510K clearance for VEEGix, its instant-use EEG

    Click Here

  • Sept 2024 - NeuroServo appoints Dr Andrew J. Cole as Chief Medical Officer

    Click Here

PRESS RELEASES

June 20, 2023

NeuroServo (instant EEG for ICU and ER) announces closing of $2.2M funding round

→ LEARN MORE

October 26, 2021

NeuroServo Inc announced that Dr François Marquis
is joining as Chief Medical Officer

→ LEARN MORE

October 12, 2021

NeuroServo Inc announces
that Health-Canada granted
a Medical Device License to VEEGix, NeuroServo’s EEG

→ LEARN MORE

July 23, 2021

NeuroServo Announces Encouraging Results from
a Clinical investigation on
Post-Operative Cerebral Complications

→ LEARN MORE

February 22, 2021

NeuroServo receives certification for its EEG device and for the company as a medical manufacturer.

→ LEARN MORE